Literature DB >> 1500826

Dimethyl sulfoxide decreases lung neutrophil sequestration and lung leak.

J A Leff1, M A Oppegard, E C McCarty, C P Wilke, P F Shanley, C E Day, N K Ahmed, L M Patton, J E Repine.   

Abstract

To investigate basic mechanisms of acute edematous lung injury (adult respiratory distress syndrome), the formylated tripeptide formyl-norleucyl-leucyl-phenylalanine (FNLP) was instilled intratracheally into hamsters. Intratracheal FNLP produced time-dependent and dose-dependent increases in neutrophils recoverable by lung lavage (neutrophil alveolitis) and leak of intravenously injected albumin into the extravascular lung space (lung leak). Treatment with dimethyl sulfoxide (DMSO) decreased (p less than 0.05) neutrophil alveolitis and lung leak in hamsters given FNLP intratracheally. The effect of DMSO on various neutrophil functions was also studied in vitro. Addition of DMSO at concentrations (about 0.20%) measured in plasma of hamsters given DMSO decreased (p less than 0.05) neutrophil chemotaxis but not neutrophil superoxide anion generation or adherence to cultured endothelial cell monolayers or nylon fiber in vitro. We conclude that intratracheal FNLP causes neutrophil alveolitis and lung leak and that DMSO treatment ameliorates these processes, possibly by inhibiting neutrophil chemotaxis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500826

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  2 in total

1.  Dimethyl Sulfoxide Attenuates Acute Lung Injury Induced by Hemorrhagic Shock/Resuscitation in Rats.

Authors:  Yu-Chi Tsung; Chih-Yang Chung; Hung-Chieh Wan; Ya-Ying Chang; Ping-Cheng Shih; Han-Shui Hsu; Ming-Chang Kao; Chun-Jen Huang
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

2.  Alpha-4/beta-1 and alpha-L/beta-2 integrins mediate cytokine induced lung leukocyte-epithelial adhesion and injury.

Authors:  L A Parmley; N D Elkins; M A Fini; Y-E Liu; J E Repine; R M Wright
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.